Steroid Receptor Coactivator-3 (SRC-3/AIB1) as a Novel Therapeutic Target in Triple Negative Breast Cancer and Its Inhibition with a Phospho-Bufalin Prodrug
Xianzhou Song(Baylor College of Medicine), Jin Wang(Baylor College of Medicine)
Cited by 38
Related Papers
Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry
|Nature Communications|2020|204
MCU complex: Exploring emerging targets and mechanisms of mitochondrial physiology and pathology
|Journal of Advanced Research|2024|34
Development of a RIPK1 degrader to enhance antitumor immunity
|Nature Communications|2024|25
Enhancing Intracellular Accumulation and Target Engagement of PROTACs with Reversible Covalent Chemistry
|bioRxiv (Cold Spring Harbor Laboratory)|2019|20
COOKIE-Pro: covalent inhibitor binding kinetics profiling on the proteome scale
|Nature Communications|2025|3